Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026)

Nuwellis' (NUWE) quarterly Total Non-Current Liabilities came in at $4.2 million in Q2 2026, up 3.11% on a YoY basis from $4.1 million in Q2 2025, and up 7.07% quarter-over-quarter from $3.9 million in Q1 2026.

Analysis

Nuwellis (NUWE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Total Non-Current Liabilities for 11 consecutive years, with $4.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities rose 3.11% year-over-year to $4.2 million; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 3.11% YoY), and the FY2025 full-year result was $3.1 million, up 8.13% from the prior year.
  • Total Non-Current Liabilities grew to $4.2 million in Q2 2026 per NUWE's latest filing, from $3.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $5.4 million in Q4 2022 and bottomed at $2.9 million in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $4.0 million across 5 years, with a median of $4.1 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities sank 37.68% in 2025, then surged 31.09% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $5.4 million in 2022, then tumbled by 31.79% to $3.7 million in 2023, then declined by 22.87% to $2.9 million in 2024, then increased by 8.13% to $3.1 million in 2025, then jumped by 35.79% to $4.2 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $4.2 million, $3.9 million, and $3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 40.46 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 2.57 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 3.68 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 3.44 Bn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn 4.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.21 Mn
Mar 31, 2026 3.93 Mn
Dec 31, 2025 3.10 Mn
Sep 30, 2025 3.65 Mn
Jun 30, 2025 4.08 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 2.87 Mn
Sep 30, 2024 3.07 Mn
Jun 30, 2024 4.44 Mn
Mar 31, 2024 4.81 Mn
Dec 31, 2023 3.72 Mn
Sep 30, 2023 3.59 Mn
Jun 30, 2023 4.48 Mn
Mar 31, 2023 4.82 Mn
Dec 31, 2022 5.45 Mn
Sep 30, 2022 4.42 Mn
Jun 30, 2022 4.33 Mn
Mar 31, 2022 4.32 Mn
Dec 31, 2021 4.29 Mn
Sep 30, 2021 3.83 Mn